Visum Pharmaceutical Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- 273-D, Nanhai Blvd., Haikou, 570311, China (CHN)
- Operations here
- analysislabelmanufacturepackrelabelrepack
- FDA identifiers
- FEI 3009283401 · DUNS 421344638
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-12-13
- NAIDrug Quality Assurance2016-01-15
Drugs this plant is listed as making
3 distinct drugs across 13 products name this site in their FDA label.
- EntecavirEpic Pharma, Llc
- Metoprolol SuccinateOryza Pharmaceuticals, Inc
- ParoxetineWestminster Pharmaceuticals, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.